Advertisement

Topics

New investment set to further establish UK as a cell and gene therapy hub

10:49 EDT 31 Aug 2017 | EPM Magazine

An award worth £12 million, from the government’s investment in healthcare and life sciences, will be used to expand the current size and capability of the Cell and Gene Therapy Catapult large-scale GMP Manufacturing Centre

Original Article: New investment set to further establish UK as a cell and gene therapy hub

NEXT ARTICLE

More From BioPortfolio on "New investment set to further establish UK as a cell and gene therapy hub"

Quick Search
Advertisement
 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...